Rebecca C. Coll, PhD

Rebecca C. Coll, PhD
Lecturer in Immunobiology and Group Leader
Wellcome-Wolfson Institute for Experimental Medicine
Queen’s University Belfast, UK
@Rebecca_Coll

Rebecca received her PhD in Immunology in 2013 from Trinity College Dublin and moved to the Institute for Molecular Bioscience at the University of Queensland in 2014 to continue her work on innate immunity and novel anti-inflammatory molecules. Rebecca joined The Wellcome-Wolfson Institute for Experimental Medicine at Queen’s University Belfast as a Lecturer in Immunobiology and principal investigator in 2019. Rebecca’s research is focused on inflammasomes – protein complexes at the heart of inflammation and disease – and how these complexes can be targeted therapeutically to prevent damaging inflammation. Rebecca led the biological characterisation of MCC950, a small molecule inhibitor of the NLRP3 inflammasome and an exciting prospect as a new therapy for treating patients with NLRP3-mediated diseases. In 2016 Rebecca was awarded the Research Australia Discovery Award for her work on NLRP3 inhibitors. 

Oral Presentation at Cytokines 2021 Hybrid Meeting: HARNESSING THE POWER OF NLRP3 – PHARMACOLOGICAL STRATEGIES FOR INHIBITION AND ACTIVATION OF THE INFLAMMASOME

For more details about the Regeneron Awards and former Milstein Young Investigator Awards, please click here.